Will G. Ryan

1.6k total citations
45 papers, 1.1k citations indexed

About

Will G. Ryan is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Will G. Ryan has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Will G. Ryan's work include Bone health and treatments (18 papers), Pancreatic function and diabetes (7 papers) and Medical Imaging and Pathology Studies (6 papers). Will G. Ryan is often cited by papers focused on Bone health and treatments (18 papers), Pancreatic function and diabetes (7 papers) and Medical Imaging and Pathology Studies (6 papers). Will G. Ryan collaborates with scholars based in United States, United Kingdom and Canada. Will G. Ryan's co-authors include Theodore Schwartz, Richard D. Penn, John D. Bagdade, Arthur H. Rubenstein, Papasani V. Subbaiah, Janet Wolter, Donald F. Steiner, F. Melani, Ethel S. Siris and Frederick R. Singer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Will G. Ryan

44 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Will G. Ryan United States 20 414 284 233 214 180 45 1.1k
P. Clifton‐Bligh Australia 21 227 0.5× 330 1.2× 332 1.4× 201 0.9× 160 0.9× 54 1.1k
Nobuo Kugai Japan 18 331 0.8× 204 0.7× 123 0.5× 393 1.8× 118 0.7× 65 1.0k
J. Silver Israel 19 206 0.5× 225 0.8× 119 0.5× 447 2.1× 541 3.0× 39 1.9k
Rita van Bree Belgium 22 242 0.6× 295 1.0× 130 0.6× 316 1.5× 148 0.8× 47 1.4k
Albert Fournier France 21 146 0.4× 235 0.8× 132 0.6× 278 1.3× 131 0.7× 40 1.5k
Marcus Schaaf United States 19 173 0.4× 785 2.8× 368 1.6× 133 0.6× 140 0.8× 32 1.4k
P A Lundberg Sweden 19 141 0.3× 845 3.0× 140 0.6× 163 0.8× 123 0.7× 46 1.8k
Omega L. Silva United States 18 269 0.6× 194 0.7× 112 0.5× 258 1.2× 36 0.2× 27 876
G Crepaldi Italy 15 450 1.1× 104 0.4× 135 0.6× 200 0.9× 52 0.3× 25 947
Stewart A. Turner United States 17 455 1.1× 93 0.3× 335 1.4× 190 0.9× 312 1.7× 27 2.1k

Countries citing papers authored by Will G. Ryan

Since Specialization
Citations

This map shows the geographic impact of Will G. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Will G. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Will G. Ryan more than expected).

Fields of papers citing papers by Will G. Ryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Will G. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Will G. Ryan. The network helps show where Will G. Ryan may publish in the future.

Co-authorship network of co-authors of Will G. Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Will G. Ryan. A scholar is included among the top collaborators of Will G. Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Will G. Ryan. Will G. Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buckler, Helen, William D. Fraser, D. J. Hosking, et al.. (1999). Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study. Bone. 24(5). 81S–85S. 35 indexed citations
2.
Siris, Ethel S., Arkadi Chines, Roy D. Altman, et al.. (1998). Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter Study. Journal of Bone and Mineral Research. 13(6). 1032–1038. 112 indexed citations
3.
Ryan, Will G., Ernest W. Fordham, & Amjad Ali. (1995). Treated Pagetʼs Disease of Bone Mimicking Metastatic Cancer. Clinical Nuclear Medicine. 20(1). 69–69. 2 indexed citations
4.
D’Angelo, Charles M., et al.. (1992). Adenocarcinoma metastatic to a growth-hormone-secreting pituitary adenoma: Case report. Surgical Neurology. 37(5). 361–365. 19 indexed citations
5.
Ryan, Will G.. (1992). Pagetʼs disease of bone and fibrous dysplasia. Current Opinion in Rheumatology. 4(3). 410–414. 1 indexed citations
6.
Ryan, Will G., J Wolter, & John D. Bagdade. (1991). Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary study. Osteoporosis International. 2(1). 39–41. 21 indexed citations
7.
Bagdade, John D., Janet Wolter, Papasani V. Subbaiah, & Will G. Ryan. (1990). Effects of Tamoxifen Treatment on Plasma Lipids and Lipoprotein Lipid Composition. The Journal of Clinical Endocrinology & Metabolism. 70(4). 1132–1135. 88 indexed citations
8.
Ryan, Will G.. (1990). Pagetʼs disease and fibrous dysplasia. Current Opinion in Rheumatology. 2(1). 8–11. 1 indexed citations
9.
Gitelis, Steven, et al.. (1986). Adult-onset hypophosphatemic osteomalacia secondary to neoplasm. A case report and review of the pathophysiology.. Journal of Bone and Joint Surgery. 68(1). 134–138. 15 indexed citations
10.
Ryan, Will G., et al.. (1984). Mithramycin and Paget's Disease Revisited. Annals of Internal Medicine. 100(5). 771–771. 1 indexed citations
11.
Gonen, Boas, José Goldman, David Baldwin, et al.. (1979). Metabolic Control in Diabetic Patients: Effect of Insulin-secretory Reserve (Measured by Plasma C-Peptide Levels) and Circulating Insulin Antibodies. Diabetes. 28(8). 749–753. 46 indexed citations
12.
Northrop, Gretajo, Will G. Ryan, & Theodore Schwartz. (1973). Propranolol-induced Insulin Release in Isolated Rat Islets of Langerhans. Diabetes. 22(2). 91–93. 6 indexed citations
13.
Northrop, Gretajo, et al.. (1972). Estriol excretion profiles in narcotic-addicted pregnant women. American Journal of Obstetrics and Gynecology. 112(5). 704–712. 10 indexed citations
14.
Ryan, Will G., et al.. (1969). The Effect of Glucola, Diet Cola and Water Ingestion on Blood Glucose and Plasma Insulin. Experimental Biology and Medicine. 131(2). 329–330. 20 indexed citations
15.
Ryan, Will G., et al.. (1969). Effects of Mithramycin on Paget's Disease of Bone.. Annals of Internal Medicine. 70(5). 1103–1104. 4 indexed citations
16.
Ryan, Will G., et al.. (1969). Effects of Mithramycin on Paget's Disease of Bone. Annals of Internal Medicine. 70(3). 549–557. 66 indexed citations
17.
Ryan, Will G., et al.. (1968). Fibrous dysplasia of bone with Vitamin D resistant rickets: A case study. Metabolism. 17(11). 988–998. 25 indexed citations
19.
Ryan, Will G., et al.. (1967). An improved extraction procedure for the determination of triglycerides and cholesterol in plasma or serum.. PubMed. 13(9). 769–72. 19 indexed citations
20.
Thompson, Willard O., et al.. (1951). The year book of endocrinology. Mosby eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026